Mai N. Van

528 total citations
13 papers, 361 citations indexed

About

Mai N. Van is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Mai N. Van has authored 13 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Mai N. Van's work include Prostate Cancer Treatment and Research (6 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer Cells and Metastasis (4 papers). Mai N. Van is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer Cells and Metastasis (4 papers). Mai N. Van collaborates with scholars based in Netherlands, Belgium and Denmark. Mai N. Van's co-authors include Stefan Sleijfer, John W.M. Martens, Jaco Kraan, Wendy Onstenk, Anieta M. Sieuwerts, Ron H.J. Mathijssen, Ronald de Wit, Paul Hamberg, Martijn P. Lolkema and John A. Foekens and has published in prestigious journals such as Nature Medicine, Cancer Research and European Urology.

In The Last Decade

Mai N. Van

12 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mai N. Van Netherlands	7	259	182	165	88	68	13	361
Ethan Barnett United States	8	291 1.1×	185 1.0×	183 1.1×	144 1.6×	39 0.6×	16	416
George Seed United Kingdom	8	289 1.1×	241 1.3×	206 1.2×	112 1.3×	32 0.5×	21	422
Lyndsey Dugan United States	6	265 1.0×	230 1.3×	250 1.5×	89 1.0×	33 0.5×	14	424
Anuradha Jayaram United Kingdom	7	332 1.3×	263 1.4×	108 0.7×	128 1.5×	69 1.0×	24	427
Karim Boudadi United States	8	175 0.7×	54 0.3×	115 0.7×	84 1.0×	31 0.5×	16	267
I. Figueiredo United Kingdom	4	123 0.5×	117 0.6×	88 0.5×	91 1.0×	18 0.3×	8	228
Takayuki Sumiyoshi Japan	11	247 1.0×	145 0.8×	90 0.5×	124 1.4×	30 0.4×	41	351
Andrea E. Doak United States	6	253 1.0×	128 0.7×	200 1.2×	161 1.8×	29 0.4×	7	350
Luigi Cerbone Italy	10	222 0.9×	93 0.5×	125 0.8×	109 1.2×	16 0.2×	40	308
Ayse Ӧzatılgan France	8	442 1.7×	148 0.8×	176 1.1×	81 0.9×	172 2.5×	21	495

Countries citing papers authored by Mai N. Van

Since Specialization

Citations

This map shows the geographic impact of Mai N. Van's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mai N. Van with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mai N. Van more than expected).

Fields of papers citing papers by Mai N. Van

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mai N. Van. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mai N. Van. The network helps show where Mai N. Van may publish in the future.

Co-authorship network of co-authors of Mai N. Van

This figure shows the co-authorship network connecting the top 25 collaborators of Mai N. Van. A scholar is included among the top collaborators of Mai N. Van based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mai N. Van. Mai N. Van is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Jongbloed, Elisabeth M., Vanja de Weerd, Corine M. Beaufort, et al.. (2025). Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial. Nature Medicine. 31(11). 3662–3667. 2 indexed citations

Van, Mai N., Jaco Kraan, Jan C. Drooger, et al.. (2024). Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial. Breast Cancer Research and Treatment. 205(1). 87–95. 3 indexed citations

Weerd, Vanja de, Mai N. Van, Jaco Kraan, et al.. (2023). Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival. npj Breast Cancer. 9(1). 61–61. 6 indexed citations

Kraan, Jaco, Mai N. Van, Leonie L. Zeune, et al.. (2020). Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients. Molecular Oncology. 15(1). 116–125. 35 indexed citations

Sieuwerts, Anieta M., Esther Oomen‐de Hoop, Bianca Mostert, et al.. (2019). Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer. European Journal of Cancer. 121. 48–54. 23 indexed citations

Sieuwerts, Anieta M., Wendy Onstenk, Jaco Kraan, et al.. (2019). Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel. Cancers. 11(8). 1212–1212. 21 indexed citations

Sieuwerts, Anieta M., Wendy Onstenk, Jaco Kraan, et al.. (2019). AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel. Molecular Oncology. 13(8). 1795–1807. 22 indexed citations

Sieuwerts, Anieta M., Bianca Mostert, Michelle van der Vlugt‐Daane, et al.. (2018). An In-Depth Evaluation of the Validity and Logistics Surrounding the Testing of AR-V7 mRNA Expression in Circulating Tumor Cells. Journal of Molecular Diagnostics. 20(3). 316–325. 15 indexed citations

Sieuwerts, Anieta M., Bianca Mostert, Michelle van der Vlugt‐Daane, et al.. (2018). Abstract 2617: A multicenter project to test the validity and logistics surrounding the testing of AR-V7 mRNA expression in circulating tumor cells. Cancer Research. 78(13_Supplement). 2617–2617. 1 indexed citations

10.

Beije, Nick, Jaco Kraan, Mai N. Van, et al.. (2017). Abstract P1-02-02: ESR1 mutations in circulating tumor cell versus circulating cell-free DNA of metastatic breast cancer patients before first-line endocrine therapy and at progression. Cancer Research. 77(4_Supplement). P1–2.

11.

Smith, Julie, Jaco Kraan, Henrik Stender, et al.. (2016). Cryopreservation of Circulating Tumor Cells for Enumeration and Characterization. Biopreservation and Biobanking. 14(4). 330–337. 4 indexed citations

12.

Onstenk, Wendy, Anieta M. Sieuwerts, Bianca Mostert, et al.. (2016). Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer. Oncotarget. 7(37). 59058–59069. 34 indexed citations

13.

Onstenk, Wendy, Anieta M. Sieuwerts, Jaco Kraan, et al.. (2015). Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells. European Urology. 68(6). 939–945. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact